Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.
about
Antiretroviral interventions for preventing breast milk transmission of HIVInfluence of infection during pregnancy on fetal developmentManagement of HIV Infection during Pregnancy in the United States: Updated Evidence-Based Recommendations and Future Potential PracticesElimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition ModelAntiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaEmergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmissionReduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and MozambiqueA Systematic Review of Interventions to Reduce Maternal Mortality among HIV-Infected Pregnant and Postpartum WomenTriple return on investment: the cost and impact of 13 interventions that could prevent stillbirths and save the lives of mothers and babies in South Africa.Risk factors of HIV-1 vertical transmission (VT) and the influence of antiretroviral therapy (ART) in pregnancy outcome.Anaemia in pregnancy is associated with advanced HIV diseaseEffectiveness of a prevention of mother-to-child HIV transmission programme in an urban hospital in AngolaHighly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.Evaluation of a quality improvement intervention to prevent mother-to-child transmission of HIV (PMTCT) at Zambia defence force facilities.HIV and maternal mortality.Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in ZambiaTrajectories of Childbearing among HIV Infected Indian Women: A Sequence Analysis ApproachEarly Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, ChinaPreterm Birth and Low Birth Weight after In Utero Exposure to Antiretrovirals Initiated during Pregnancy in Yaoundé, CameroonOption B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda."They told me to come back": women's antenatal care booking experience in inner-city Johannesburg.Duration of cART Before Delivery and Low Infant Birthweight Among HIV-Infected Women in Lusaka, Zambia.A comprehensive review of the barriers and promoters health workers experience in delivering prevention of vertical transmission of HIV services in sub-Saharan Africa.Paternal involvement and fetal morbidity outcomes in HIV/AIDS: a population-based study.Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes.Antiretroviral therapy and preterm birth in HIV-infected women.Impact of maternal HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.Factors associated with mother-to-child transmission of the human immunodeficiency virus in Pernambuco, Brazil, 2000-2009.Impact of Extended Combination Antiretroviral Therapy on the Decline of HIV Prevalence in Pregnant Women in Malawi.Maternal Antiretroviral Therapy Is Associated with Lower Risk of Diarrhea in Early Childhood.Incidence of pregnancy among women accessing antiretroviral therapy in urban Malawi: a retrospective cohort study.PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.Perspectives on safer conception practices and preconception counseling among women living with HIV.Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.Darunavir for Use in Pregnant Women with HIV.In Utero ART Exposure and Birth and Early Growth Outcomes Among HIV-Exposed Uninfected Infants Attending Immunization Services: Results From National PMTCT Surveillance, South Africa.Induced first abortion rates before and after HIV diagnosis: results of an Italian self-administered questionnaire survey carried out in 585 women living with HIV.Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.Progress in Mozambique: Changes in the availability, use, and quality of emergency obstetric and newborn care between 2007 and 2012
P2860
Q22252958-F043AC1A-B0CD-46DB-B845-D53DBBC2E12DQ24276210-F419A4D8-A8A7-408F-88FD-F01122DECB01Q26738453-4AB63FE6-629B-410D-BDAC-F142D9205CB2Q26778483-D0C2E2B5-3478-4BD3-B1C7-D5FEB3BB808AQ27014960-679E7DC8-6C2B-422B-9B2A-E945FCAF1AE5Q28481233-3D557E38-04F4-4DE5-9D18-47BEDD0281C8Q28535436-6D7DA060-FE09-4117-9EBB-BA4DA8A37123Q30381808-9DAF83AB-A824-4471-976D-801D20200C7BQ30389521-71A8991D-BD3D-477C-B68D-3B9A81C05641Q33859660-769937E3-3E56-4901-8424-649928F70EBDQ34183235-B065637C-BBEC-4AE0-8C5D-7C8888746313Q34257477-5AD8E0B7-98D9-4E71-91B9-F2CBD7640DECQ34306176-67C89FC1-3BF9-46DD-8D69-853681CD59E2Q34980431-547FE2A9-422C-46CF-8F64-8641B92291F2Q34997187-A3199570-0F9D-41AD-8F52-8FEE075D2DA5Q35031969-959F7008-14D6-4AD2-BAAA-E271A07DDE32Q35113480-B1AF9357-091D-4D83-A0A1-9C8D956CDDEAQ35532777-159CA2E8-3D13-4BCC-936E-5B193B01EEF9Q35788503-F4AB54A4-9370-4056-A510-67A7C6E23543Q35964999-ABD782B7-2E29-423E-A4F1-8422D6272EA2Q36300046-42E05F76-A665-427C-B872-65740BC23743Q36654965-97FD3E96-B9F7-41D1-B2B6-2D278BAB6962Q36678190-9E1B5038-CA28-4A98-A1FE-19B530B2A1BFQ37162002-E2536D05-FBD7-472A-A14C-1B3D1962E09AQ37540798-62A9B211-D6D5-494E-A1BC-D59940FA64FBQ37836433-EE1A7B01-4307-480B-B446-D4B49FAA6C28Q38185748-2989195A-1820-4D61-9B0A-5BA0CC5AC055Q38890564-D3DB4298-241B-4095-86B1-92C06F795FE7Q38959478-83163C3D-D36E-4A74-8991-0937BE95335AQ39182497-63B6880B-4523-4A83-A22D-A42C4EF5224DQ39721973-6F6727E1-6433-451F-879B-D898DDD18682Q40022738-5B132CC1-C4DE-4704-9694-A85AB5006780Q40440550-7C8D7753-8C50-4B52-B0D2-4E1C0B709DCDQ40941013-2C9A29C0-1F2F-41FB-B826-F598E2279EF1Q41057198-6A779824-B507-4A9F-8249-8F25E92D2983Q41922010-4B3FE1CC-0C72-4C24-B488-52FA080F0712Q46942896-D4744EB7-63BA-4222-AB9B-FDEFD9820A48Q47579694-39211458-6C8A-4FFE-8190-77490B06BEC0Q48206030-5F7A4378-2C05-4711-883D-5F33600C79ABQ57930134-5CE929D1-3405-42B0-B66E-5B1054495FB2
P2860
Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extended antenatal use of trip ...... favorable pregnancy outcomes.
@en
Extended antenatal use of trip ...... favorable pregnancy outcomes.
@nl
type
label
Extended antenatal use of trip ...... favorable pregnancy outcomes.
@en
Extended antenatal use of trip ...... favorable pregnancy outcomes.
@nl
prefLabel
Extended antenatal use of trip ...... favorable pregnancy outcomes.
@en
Extended antenatal use of trip ...... favorable pregnancy outcomes.
@nl
P2093
P50
P921
P1433
P1476
Extended antenatal use of trip ...... favorable pregnancy outcomes.
@en
P2093
Giovanna Paturzo
Ines Zimba
Jere Haswell
Nurja A Magid
Pasquale Narciso
Susanna Ceffa
P304
P356
10.1097/QAD.0B013E3283493ED0
P407
P50
P577
2011-08-01T00:00:00Z